Not logged in Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: a biomarker analysis from the NEOLAP trial (AIO-PAK-0113) Kimmel, B.; Loehnert, S. T.; Wedekink, F.; Guenther, M.; Ormanns, S.; Hartlapp, I.; Siveke, J.; Siegler, G.; Boeck, S.; Alguel, H.; Martens, U.; Kullmann, F.; Ettrich, T.; Held, S.; Anger, F.; Germer, C. -t.; Heinemann, V.; Wischhusen, J.; Kunzmann, V. Share Save
Share Save
Share Save
Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer (vol 615, pg 168, 2023) Tintelnot, Joseph; Xu, Yang; Lesker, Till R.; Schoenlein, Martin; Konczalla, Leonie; Giannou, Anastasios D.; Pelczar, Penelope; Kylies, Dominik; Puelles, Victor G.; Bielecka, Agata A.; Peschka, Manuela; Cortesi, Filippo; Riecken, Kristoffer; Jung, Maximilian; Amend, Lena; Broering, Tobias S.; Trajkovic-Arsic, Marija; Siveke, Jens T.; Renne, Thomas; Zhang, Danmei; Boeck, Stefan; Strowig, Till; Uzunoglu, Faik G.; Guengoer, Cenap; Stein, Alexander; Izbicki, Jakob R.; Bokemeyer, Carsten; Sinn, Marianne; Kimmelman, Alec C.; Huber, Samuel; Gagliani, Nicola Share Save
The Prognostic, Predictive and Clinicopathological Implications of KRT81/HNF1A- and GATA6-Based Transcriptional Subtyping in Pancreatic Cancer Guenther, Michael; Surendran, Sai Agash; Steinke, Lea Margareta; Liou, Iduna; Palm, Melanie Alexandra; Heinemann, Volker; Haas, Michael; Boeck, Stefan; Ormanns, Steffen Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
Alternating gemcitabine plus nab-paclitaxel and gemcitabine alone versus continuous gemcitabine plus nab-paclitaxel after induction treatment of metastatic pancreatic cancer (ALPACA): a multicentre, randomised, open-label, phase 2 trial Dorman, Klara; Boeck, Stefan; Caca, Karel; Reichert, Maximilian; Ettrich, Thomas J.; Oettle, Helmut; Waidmann, Oliver; Modest, Dominik P.; Mueller, Lothar; Michl, Patrick; Kanzler, Stephan; Pink, Daniel; Reinacher-Schick, Anke; Geissler, Michael; Pelz, Henning; Kunzmann, Volker; Held, Swantje; Schichtl, Thomas; Heinemann, Volker; Kullmann, Frank Share Save
Nanoliposomal irinotecan and fluorouracil plus leucovorin versus fluorouracil plus leucovorin in patients with cholangiocarcinoma and gallbladder carcinoma previously treated with gemcitabine-based therapies (AIO NALIRICC) a multicentre, open-label, randomised, phase 2 trial Vogel, Arndt; Saborowski, Anna; Wenzel, Patrick; Wege, Henning; Folprecht, Gunnar; Kretzschmar, Albrecht; Schuett, Philipp; Jacobasch, Lutz; Ziegenhagen, Nicolas; Boeck, Stefan; Zhang, Danmei; Kanzler, Stephan; Belle, Sebastian; Mohm, Johannes; Goekkurt, Eray; Lerchenmueller, Christian; Graeven, Ullrich; Pink, Daniel; Goetze, Thorsten; Kirstein, Martha M. Share Save
Unresectable biliary tract cancer: Current and future systemic therapy Zhang, Danmei; Dorman, Klara; Westphalen, C. Benedikt; Haas, Michael; Ormanns, Steffen; Neumann, Jens; Seidensticker, Max; Ricke, Jens; De Toni, Enrico N.; Klauschen, Frederick; Alguel, Hana; Reislaender, Timo; Boeck, Stefan; Heinemann, Volker Share Save
Prognostic and predictive value of CA 19-9 in locally advanced pancreatic cancer treated with multiagent induction chemotherapy: results from a prospective, multicenter phase II trial (NEOLAP-AIO-PAK-0113) (vol 7, 100552, 2024) Hartlapp, I.; Valta-Seufzer, D.; Siveke, J. T.; Alguel, H.; Goekkurt, E.; Siegler, G.; Martens, U. M.; Waldschmidt, D.; Pelzer, U.; Fuchs, M.; Kullmann, F.; Boeck, S.; Ettrich, T. J.; Held, S.; Keller, R.; Anger, F.; Germer, C. T.; Stang, A.; Kimmel, B.; Heinemann, V.; Kunzmann, V. Share Save
Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study group Weiss, L.; Fischer, L. E.; Heinemann, V.; Gieseler, F.; Hoehler, T.; Mayerle, J.; Quietzsch, D.; Reinacher-Schick, A.; Schenk, M.; Seipelt, G.; Siveke, J. T.; Stahl, M.; Kaiser, U.; Waldschmidt, D. T.; Dorman, K.; Zhang, D.; Westphalen, C. B.; Boeck, S.; Haas, M. Share Save
Gemcitabine and nab-paclitaxel combined with afatinib in metastatic pancreatic cancer - Results of a phase 1b clinical trial Zhang, Danmei; Westphalen, C. Benedikt; Quante, Michael; Waldschmidt, Dirk T.; Held, Swantje; Kuetting, Fabian; Dorman, Klara; Heinrich, Kathrin; Weiss, Lena; Boukovala, Myrto; Haas, Michael; Boeck, Stefan; Heinemann, Volker; Probst, Victoria Share Save
Screening and COnsensus based on Practices and Evidence (SCOPE): Real-world survey on Japanese and rest-of-world practice patterns in resectable pancreatic cancer Fujii, T.; Prager, G.; Boeck, S.; Santini, D.; Modest, D. P.; Rivera, F.; Phelip, J. M.; Dioca, M. H.; Smyth, E.; Zaanan, A.; Wasan, H. S.; Furuse, J. Share Save
A Retrospective Analysis of Biliary Tract Cancer Patients Presented to the Molecular Tumor Board at the Comprehensive Cancer Center Munich Zhang, Danmei; Dorman, Klara; Heinrich, Kathrin; Weiss, Lena; Boukovala, Myrto; Haas, Michael; Greif, Philipp A. A.; Ziemann, Frank; Beyer, Georg; Roessler, Daniel; Goni, Elisabetta; Renz, Bernhard; D'Haese, Jan G. G.; Kunz, Wolfgang G.; Seidensticker, Max; Corradini, Stefanie; Niyazi, Maximilian; Ormanns, Steffen; Kumbrink, Jorg; Jung, Andreas; Mock, Andreas; Rudelius, Martina; Klauschen, Frederick; Werner, Jens; Mayerle, Julia; von Bergwelt-Baildon, Michael; Boeck, Stefan; Heinemann, Volker; Westphalen, C. Benedikt Share Save
Real-world screening and consensus based on practices and evidence (SCOPE) in gastrointestinal cancers: Practice patterns in metastatic pancreatic cancer Prager, G.; Fujii, T.; Santini, D.; Modest, D.; Rivera, F.; Phelip, J.; Dioca, M.; Smyth, E.; Zaanan, A.; Wasan, H.; Boeck, S. Share Save
The screening and consensus based on practices and evidence (SCOPE) survey - results of a real-world survey on practice patterns in gastric cancer Smyth, E.; Modest, D.; Prager, G.; Santini, D.; Rivera, F.; Phelip, J.; Dioca, M.; Wasan, H.; Boeck, S.; Zaanan, A. Share Save
Current practices in metastatic colorectal cancer: Results from the real-world screening and consensus based on practices and evidence (SCOPE) program in gastrointestinal cancers Prager, G.; Santini, D.; Modest, D.; Rivera, F.; Phelip, J.; Dioca, M.; Smyth, E.; Zaanan, A.; Boeck, S.; Wasan, H. Share Save
Single-center real-world experience from 18 consecutive cases treated with durvalumab in combination with chemotherapy for advanced biliary tract cancer Zhang, D.; Heinemann, V.; Haas, M.; Heinrich, K.; Weiss, L.; Boukovala, M.; Probst, V.; Anna, R.; Beyer, G.; von Bergwelt-Baldion, M.; Westphalen, B.; Boeck, S.; Dorman, K. Share Save
Changes in the course of advanced pancreatic cancer treatment with systemic chemotherapy: A pooled analysis of five clinical trials from two decades of clinical research within the German AIO Study-Group Weiss, L.; Heinemann, V.; Fischer, L.; Gieseler, F.; Hoehler, T.; Mayerle, J.; Quietzsch, D.; Reinacher-Schick, A.; Schenk, M.; Seipelt, G.; Siveke, J.; Stahl, M.; Vehling-Kaiser, U.; Waldschmidt, D.; Dorman, K.; Zhang, D.; Westphalen, B.; Haas, M.; Boeck, S. Share Save
Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
